BIOMARIN PHARMACEUTICAL INC: operating_income
| Value | {"amount": -123524000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-12-31 |
| Status | current |
| Entity | BIOMARIN PHARMACEUTICAL INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f6f462a2-2c90-42ff-8005-09be4a4d23b8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-19-005033Retrieved: 2026-08-19T10:17:13.171852+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001048477/operating-income/2018-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f6f462a2-2c90-42ff-8005-09be4a4d23b8
History
- no predecessors — first report